« Previous
Next »
Titles
- F as in fat: how obesity policies are failing in America1
- F as in fat: how obesity policies are failing in America : 20071
- F as in fat: how obesity policies are failing in America : 20081
- F as in fat: how obesity policies are failing in America : 20091
- F as in fat: how obesity threatens America's future : 20101
- F as in fat: how obesity threatens America's future : 20121
- FAQs: what's the latest on IPAB?1
- FDA 75, 1906-1981: pioneers in consumer protection1
- FDA categorization of investigational device exemption (IDE) devices to assist the Centers for Medicare and Medicaid Services (CMS) with coverage decisions: guidance for sponsors, clinical investigators, industry, institutional review boards, and Food and Drug Administration staff1
- FDA could take stronger enforcement action against tobacco retailers with histories of sales to youth and other violations1
- FDA deems certain tobacco products subject to FDA authority, sales and distribution restrictions, and health warning requirements for packages and advertisements: (revised)1
- FDA drug approval: application review times largely reflect FDA goals : report to Congressional requesters1
- FDA drug approval: application review times largely reflect agency goals : report to Congressional requesters1
- FDA medical device reviews: evaluation is needed to assure requests for additional information follow a least burdensome approach : report to Congressional requestors1
- FDA oversight4
- FDA oversight of tobacco manufacturing establishments1
- FDA repeatedly adapted emergency use authorization policies to address the need for COVID-19 testing1
- FDA should further integrate its review of cybersecurity into the premarket review process for medical devices1
- FDA’s approach to overseeing online tobacco retailers needs improvement1
- FDA’s risk evaluation and mitigation strategies: uncertain effectiveness in addressing the opioid crisis1